Benitec Biopharma Ltd ADR (BNTC) Annual Income Statement (USD)
BNTC Quarterly Financials (USD)
Frequently Asked Questions About Benitec Biopharma Ltd ADR (BNTC) Stock
Benitec Biopharma Ltd ADR's (BNTC) last reported annual revenue was USD 75000.00.
Benitec Biopharma Ltd ADR's (BNTC) annual revenue growth rate based on the revenue reported in the past 5 years is : -30.29%
Benitec Biopharma Ltd ADR's(BNTC) is not profitable as of its last reported annual financials.
The net profit margin for Benitec Biopharma Ltd ADR's(BNTC) from its laster reported year is -26082.67%
The return on equity (ROE) for Benitec Biopharma Ltd ADR's(BNTC) from its last reported annual financials is : -178.30%
The return on assets (ROA) for Benitec Biopharma Ltd ADR's(BNTC) from its last reported annual financials is : -81.53%
The return on invested capital (ROIC) for Benitec Biopharma Ltd ADR's(BNTC) from its last reported annual financials is : -1237.61%
The Debt to Equity ratio for Benitec Biopharma Ltd ADR's(BNTC) from its last reported annual financials is : 0.00%
The dividend yield for Benitec Biopharma Ltd ADR's(BNTC) from its laster reported year is 0.00%
Benitec Biopharma Ltd ADR's(BNTC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BNTC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
